- Presentations
- 2
- Markets
- 1
Darzalex IV is a brand of Daratumumab marketed by Janssen Biotech, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Daratumumab
- Brand owner
- Janssen Biotech
- Registered in
- United States
- Strengths and forms
- 100 mg/5 mL injection, 400 mg/20 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Darzalex IV 100 mg/5 mL injectionIntravenous Cold chain | Janssen Biotech | US FDA | Available on request |
| Darzalex IV 400 mg/20 mL injectionIntravenous Cold chain | Janssen Biotech | US FDA | Available on request |
Equivalent brands
Other brands of Daratumumab.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Darzalex IV
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.